Cathy N Lam

Array ( [id] => 10121567 [patent_doc_number] => 09155914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Composition for external application to skin' [patent_app_type] => utility [patent_app_number] => 12/742525 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7591 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12742525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8944114 [patent_doc_number] => 08497293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides' [patent_app_type] => utility [patent_app_number] => 12/741896 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12520 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12741896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994988 [patent_doc_number] => 08518872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy' [patent_app_type] => utility [patent_app_number] => 12/739139 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12480 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433276 [patent_doc_number] => 20100278776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR MODULATING A KINASE CASCADE AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/738528 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 46157 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278776.pdf [firstpage_image] =>[orig_patent_app_number] => 12738528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497850 [patent_doc_number] => 20100286157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => '4- [3- (4-CYCLOPROPANECARBONYL-PIPERAZINE-I-CARBONYL) -4 -FLUORO-BENZYL] -2H-PHTHALAZ IN-1-ONE' [patent_app_type] => utility [patent_app_number] => 12/738181 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6230 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286157.pdf [firstpage_image] =>[orig_patent_app_number] => 12738181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441874 [patent_doc_number] => 20090093513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Method to Use Compositions Having Antidepressant Anxiolytic and Other Neurological Activity and Compositions of Matter' [patent_app_type] => utility [patent_app_number] => 12/248234 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8610 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093513.pdf [firstpage_image] =>[orig_patent_app_number] => 12248234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954272 [patent_doc_number] => 20110034480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'COMPOSITIONS COMPRISING CETIRIZINE AND A NON BETA-2-ADRENORECEPTOR AGONIST, A BETA-2-ADRENORECEPTOR AGONIST OR AN ANTI-INFLAMMATORY AND THE USE THEREOF FOR THE TREATMENT OF RESPIRATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/681467 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2656 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034480.pdf [firstpage_image] =>[orig_patent_app_number] => 12681467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401839 [patent_doc_number] => 20100305104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Oxadiazole Diaryl Compounds' [patent_app_type] => utility [patent_app_number] => 12/675254 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34017 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305104.pdf [firstpage_image] =>[orig_patent_app_number] => 12675254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11450302 [patent_doc_number] => 09573933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-21 [patent_title] => 'Inhibitors of the interaction between MDM2 and P53' [patent_app_type] => utility [patent_app_number] => 12/678961 [patent_app_country] => US [patent_app_date] => 2008-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29827 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324548 [patent_doc_number] => 20090062538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'AMORPHOUS VALGANCICLOVIR HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 12/204949 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3995 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062538.pdf [firstpage_image] =>[orig_patent_app_number] => 12204949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538490 [patent_doc_number] => 20100204293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/676346 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5374 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204293.pdf [firstpage_image] =>[orig_patent_app_number] => 12676346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664425 [patent_doc_number] => 08377886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal disease' [patent_app_type] => utility [patent_app_number] => 12/733339 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10659 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337848 [patent_doc_number] => 20090054312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'SMIPs: Small molecule inhibitors of p27 depletion in cancers and other proliferative diseases' [patent_app_type] => utility [patent_app_number] => 12/229411 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18400 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054312.pdf [firstpage_image] =>[orig_patent_app_number] => 12229411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561769 [patent_doc_number] => 20110275602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'PHARMACEUTICAL ASSOCIATION, COMPOSITIONS FOR TOPICAL USE, FORMS OF DOSAGE AND METHOD OF TREATMENT OF ACUTE OR CHRONIC OTITIS IN PET ANIMALS' [patent_app_type] => utility [patent_app_number] => 12/671750 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3258 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275602.pdf [firstpage_image] =>[orig_patent_app_number] => 12671750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6515672 [patent_doc_number] => 20100216794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'PYRIDINE DERIVATIVES USEFUL AS GLUCOKINASE ACTIVATORS' [patent_app_type] => utility [patent_app_number] => 12/682055 [patent_app_country] => US [patent_app_date] => 2008-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25547 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216794.pdf [firstpage_image] =>[orig_patent_app_number] => 12682055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520954 [patent_doc_number] => 20090028935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'CARVEDILOL FORMS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/183453 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21614 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028935.pdf [firstpage_image] =>[orig_patent_app_number] => 12183453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136578 [patent_doc_number] => 20110009396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'TRICYCLIC COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/670701 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27332 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009396.pdf [firstpage_image] =>[orig_patent_app_number] => 12670701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520963 [patent_doc_number] => 20090028944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING MESALAMINE' [patent_app_type] => utility [patent_app_number] => 12/173875 [patent_app_country] => US [patent_app_date] => 2008-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5805 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028944.pdf [firstpage_image] =>[orig_patent_app_number] => 12173875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034941 [patent_doc_number] => 20130237579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ONE OR MORE HMG-COA REDUCTAS INHIBITIORS' [patent_app_type] => utility [patent_app_number] => 12/668544 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3184 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12668544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097552 [patent_doc_number] => 20110003780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'HYDROGEN CHLORIDE SALT OF A SUBSTITUTED 5-OXAZOL-2-YL-QUINOLINE COMPOUND AND A PROCESS FOR THE PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/668191 [patent_app_country] => US [patent_app_date] => 2008-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7322 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003780.pdf [firstpage_image] =>[orig_patent_app_number] => 12668191 [rel_patent_id] =>[rel_patent_doc_number] =>)